Frazier Life Sciences Public Overage Fund, L.P. — Form D
Frazier Life Sciences Public Overage Fund, L.P. of PALO ALTO, CA, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-04-14. The offering totals $243.1M, of which $243.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-04-14
- Form: D
- Accession: 0000897069-22-000209
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $243.1M
- Amount sold: $243.1M
- Minimum investment: $4K
- Investors: 61
- Date of first sale: 2022-03-31
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-441805
Issuer
- Name: Frazier Life Sciences Public Overage Fund, L.P.
- CIK: 0001913804
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1001 PAGE MILL ROAD, PALO ALTO, CA, 94304
- Phone: (650) 325-5156
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| STEVE BAILEY | Executive Officer | SEATTLE, WA |
| --- FHMLSP Overage, L.L.C. | Promoter | Menlo Park, CA |
| --- FHMLSP Overage, L.P. | Promoter | Menlo Park, CA |
| Steve R Bailey | Executive Officer | Seattle, WA |
| N/A FHMLSP Overage, L.P. | Promoter | Palo Alto, CA |
| N/A FHMLSP Overage, L.L.C. | Promoter | Palo Alto, CA |
Other filings by this issuer (2)
More